WO2011119288A3 - Multilayer melt-extruded film - Google Patents
Multilayer melt-extruded film Download PDFInfo
- Publication number
- WO2011119288A3 WO2011119288A3 PCT/US2011/026230 US2011026230W WO2011119288A3 WO 2011119288 A3 WO2011119288 A3 WO 2011119288A3 US 2011026230 W US2011026230 W US 2011026230W WO 2011119288 A3 WO2011119288 A3 WO 2011119288A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extruded film
- active ingredient
- multilayer melt
- melt
- extruded
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020127027983A KR20130010482A (en) | 2010-03-26 | 2011-02-25 | Multilayer melt-extruded film |
EP11707305.6A EP2552402B1 (en) | 2010-03-26 | 2011-02-25 | Multilayer melt-extruded film |
JP2013501273A JP5749790B2 (en) | 2010-03-26 | 2011-02-25 | Multilayer melt extrusion film |
CN201180016068.3A CN102821754B (en) | 2010-03-26 | 2011-02-25 | Multilayer melt-extruded film |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31789310P | 2010-03-26 | 2010-03-26 | |
US61/317,893 | 2010-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011119288A2 WO2011119288A2 (en) | 2011-09-29 |
WO2011119288A3 true WO2011119288A3 (en) | 2012-05-24 |
Family
ID=43901622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/026230 WO2011119288A2 (en) | 2010-03-26 | 2011-02-25 | Multilayer melt-extruded film |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110236443A1 (en) |
EP (1) | EP2552402B1 (en) |
JP (1) | JP5749790B2 (en) |
KR (1) | KR20130010482A (en) |
CN (1) | CN102821754B (en) |
WO (1) | WO2011119288A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
CN105816434B (en) * | 2016-04-19 | 2019-09-17 | 山东新华制药股份有限公司 | Ibuprofen granule and preparation method thereof |
KR101790666B1 (en) * | 2017-06-27 | 2017-10-26 | (주)조안엠앤에스 | Orally Disintegrating Film for Pet |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19852826A1 (en) * | 1998-11-17 | 2000-05-18 | Aventis Res & Tech Gmbh & Co | Poly (alpha-1,4-D-glucan) |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
WO2007112285A2 (en) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Process for the preparation of a hot-melt extruded laminate |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA849081A (en) | 1967-03-02 | 1970-08-11 | Du Pont Of Canada Limited | PRODUCTION OF ETHYLENE/.alpha.-OLEFIN COPOLYMERS OF IMPROVED PHYSICAL PROPERTIES |
US4645812A (en) * | 1983-02-28 | 1987-02-24 | Henkel Corporation | Method of suspension polymerization of vinyl chloride |
US4729190A (en) * | 1983-10-27 | 1988-03-08 | Ciba-Geigy Corporation | Membrane-forming polymeric systems |
US5272236A (en) * | 1991-10-15 | 1993-12-21 | The Dow Chemical Company | Elastic substantially linear olefin polymers |
TW207987B (en) | 1991-03-20 | 1993-06-21 | Hoechst Ag | |
CA2108575C (en) * | 1991-04-16 | 2002-10-22 | Kouichi Nakamichi | Method of manufacturing solid dispersion |
US5278272A (en) | 1991-10-15 | 1994-01-11 | The Dow Chemical Company | Elastic substantialy linear olefin polymers |
ID16442A (en) | 1996-01-22 | 1997-10-02 | Dow Chemical Co | WEIGHT POLYMER ETHYLENE ULTRA LOW MOLECULES |
US7666337B2 (en) * | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
US20040180077A1 (en) * | 2003-03-05 | 2004-09-16 | Riker Donald K. | Rapidly dissolving edible strips for treating obesity |
US20050186257A1 (en) | 2004-02-20 | 2005-08-25 | Todd Manegold | Dissolvable film and method of manufacture |
WO2008089151A2 (en) * | 2007-01-12 | 2008-07-24 | Monosol Rx, Llc | High dose film compositions and methods of preparation |
JP5165428B2 (en) * | 2008-03-18 | 2013-03-21 | 日生化学株式会社 | Laminated body |
-
2011
- 2011-02-25 CN CN201180016068.3A patent/CN102821754B/en not_active Expired - Fee Related
- 2011-02-25 US US13/035,203 patent/US20110236443A1/en not_active Abandoned
- 2011-02-25 WO PCT/US2011/026230 patent/WO2011119288A2/en active Application Filing
- 2011-02-25 EP EP11707305.6A patent/EP2552402B1/en not_active Not-in-force
- 2011-02-25 KR KR1020127027983A patent/KR20130010482A/en not_active Application Discontinuation
- 2011-02-25 JP JP2013501273A patent/JP5749790B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19852826A1 (en) * | 1998-11-17 | 2000-05-18 | Aventis Res & Tech Gmbh & Co | Poly (alpha-1,4-D-glucan) |
US6375963B1 (en) * | 1999-06-16 | 2002-04-23 | Michael A. Repka | Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
WO2007112285A2 (en) * | 2006-03-24 | 2007-10-04 | Auxilium Pharmaceuticals, Inc. | Process for the preparation of a hot-melt extruded laminate |
Also Published As
Publication number | Publication date |
---|---|
US20110236443A1 (en) | 2011-09-29 |
CN102821754A (en) | 2012-12-12 |
EP2552402B1 (en) | 2016-11-23 |
CN102821754B (en) | 2014-06-18 |
EP2552402A2 (en) | 2013-02-06 |
JP2013523635A (en) | 2013-06-17 |
KR20130010482A (en) | 2013-01-28 |
WO2011119288A2 (en) | 2011-09-29 |
JP5749790B2 (en) | 2015-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013158814A8 (en) | Immediate release, abuse deterrent pharmaceutical compositions | |
WO2011119288A3 (en) | Multilayer melt-extruded film | |
WO2012021415A3 (en) | Oral compositions comprising a zinc compound and an anti-microbial agent | |
EP3679924A3 (en) | Formulation comprising particles | |
ECSP12012148A (en) | SOLID COMPOSITIONS | |
WO2009117130A3 (en) | Extended release forumulation containing a wax | |
WO2011088199A3 (en) | Stabilization of zinc oxide film in oral compositions | |
WO2013143968A3 (en) | Multilayered films capable of releasing active ingredients over a limited time period | |
MX2014011815A (en) | Immediate release pharmaceutical compositions with abuse deterrent properties. | |
WO2012038061A3 (en) | Nanocapsules containing microemulsions | |
WO2010138547A3 (en) | Higher loading zinc-containing films | |
WO2007117556A3 (en) | Pharmaceutical compositions and uses thereof | |
WO2009097480A3 (en) | Near infra-red pulsed laser triggered drug release from hollow nanoshell disrupted vesicles and vesosomes | |
WO2010005732A3 (en) | Composition and method of preparation of release systems for constant (zero-order) release of active agents | |
WO2012054464A3 (en) | Multilayer medical sponge | |
PH12016502537A1 (en) | Composite preparation comprising active ingredient-containing film coating layer | |
WO2014016671A3 (en) | Formulations and methods of manufacturing formulations for use in colonic evacuation | |
WO2012035046A3 (en) | Polysaccharide coating with gel particles | |
EA201490500A1 (en) | MULTILAYER PRESSURE RELATING COMPOSITION | |
WO2013096308A3 (en) | Methods for improving multimodal polyethylene and films produced therefrom | |
PH12017502426A1 (en) | Solid pharmaceutical compositions for treating hcv | |
WO2010079052A3 (en) | Nanoparticle compositions | |
EP3962533A4 (en) | Trans-tympanic membrane delivery platform and uses thereof | |
UA102680C2 (en) | Unit dosage form comprising a polyvinyl alcohol-polyethylene glycol graft copolymer and steroidal estrogen | |
PH12018500132A1 (en) | Solid pharmaceutical compositions for treating hcv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180016068.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11707305 Country of ref document: EP Kind code of ref document: A2 |
|
REEP | Request for entry into the european phase |
Ref document number: 2011707305 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 8103/CHENP/2012 Country of ref document: IN Ref document number: 2011707305 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013501273 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20127027983 Country of ref document: KR Kind code of ref document: A |